Touat, M., Li, Y., Boynton, A., Spurr, L., Iorgulescu, B., Birzu, C., Pal, S., Ferrer-Luna, R., Geduldig, J., Bellamy, C., Younan, N., Baldini, C., Verreault, M., Guillerm, E., Ammari, S., Beuvon, F., Mokhtari, K., Alentorn, A., Dehais, C., Houiller, C., Laigle-Donadey, F., Lee, E., Nayak, L., Carpentier, A., Cornu, P., mathon, B., Bi, W., Chiocca, E., Alexandrescu, S., Chi, S., Haas-Kogan, D., Alexander, B., Huang, R., Ligon, A., Coulet, F., Delattre, J., Hoang-Xuan, K., Meredith, D., Santagata, S., Duval, A., Sanson, M., Cherniack, A., Wen, P., Reardon, D., Marabelle, A., Idbaih, A., Beroukhim, R., Bandopadhayay, P., Bielle, F., & Ligon, K. (n.d.). dRES-08. CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS. Neuro-oncology, 21, vi73. http://access.bl.uk/ark:/81055/vdc_100101668189.0x000035